BLU-U
DUSA Pharmaceuticals Inc.
Application Filed: 1997-10-27
Trademark Application Details
REGISTERED AND RENEWED
| Research |
OneLook
Acronym Finder
|
| Serial Number | 75379349 |
| Registration Number | 2478294 |
| Mark Drawing Code | 1000: Typeset: Word(s)/letter(s)/number(s) |
| Law Office Assigned | L50 |
| Employee Name | MCMORROW, RONALD G |
Timeline
| 1997-10-00 | Date of First Use |
| 1997-10-27 | Application Filed |
| 1999-02-16 | Published for Opposition |
| 2001-08-14 | Trademark Registered |
| 2010-09-16 | Location: GENERIC WEB UPDATE |
| 2010-09-16 | Status: Live/Registered |
| 2011-08-14 | Renewal Date |
| 2018-07-08 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  DUSA Pharmaceuticals Inc. |
| Address | 400 Columbus Avenue Valhalla NJ 10595 |
| Legal Entity Type | Corporation |
| Legal Entity State | NJ |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 10 |
| U.S. Codes: | 026,039,044 |
| Type Code | Type |
|---|---|
| GS0101 | non-laser blue light producing device to be used in conjunction with pharmaceutical products or preparations to produce a therapeutic or diagnostic treatment of dermatological conditions |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| ASSIGNED TO EXAMINER | 1998-06-15 | 1 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION MAILED | 1998-06-19 | 2 CNRT F:First Action |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 1998-10-06 | 3 CRFA I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 1998-10-13 | 4 CRFA I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 1998-11-02 | 5 CNSA P: |
| NOTICE OF PUBLICATION | 1999-01-15 | 6 NPUB O:Outgoing Correspondence |
| PUBLISHED FOR OPPOSITION | 1999-02-16 | 7 PUBO A:Allowance for Publication |
| NOA MAILED - SOU REQUIRED FROM APPLICANT | 1999-05-11 | 8 NOAM O:Outgoing Correspondence |
| EXTENSION 1 FILED | 1999-11-04 | 9 EXT1 S: |
| EXTENSION 1 GRANTED | 1999-12-13 | 10 EX1G S: |
| EXTENSION 2 FILED | 2000-05-11 | 11 EXT2 S: |
| USE AMENDMENT FILED | 2000-05-11 | 12 IUAF S: |
| EXTENSION 2 GRANTED | 2000-07-06 | 13 EX2G S: |
| STATEMENT OF USE PROCESSING COMPLETE | 2000-07-07 | 14 SUPC I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2000-07-10 | 15 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION MAILED | 2000-07-17 | 16 CNRT S: |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2000-11-13 | 17 CRFA I:Incoming Correspondence |
| ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | 2001-03-20 | 18 CNPR P: |
| REGISTERED-PRINCIPAL REGISTER | 2001-08-14 | 19 R.PR A:Allowance for Publication |
| CASE FILE IN TICRS | 2007-02-09 | 20 CFIT O:Outgoing Correspondence |
| PAPER RECEIVED | 2007-08-16 | 21 MAIL I:Incoming Correspondence |
| REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED | 2007-08-16 | 22 815F I:Incoming Correspondence |
| ASSIGNED TO PARALEGAL | 2007-09-06 | 23 PLGL A:Allowance for Publication |
| REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | 2007-09-13 | 24 C15A O:Outgoing Correspondence |
| TEAS SECTION 8 & 9 RECEIVED | 2010-09-15 | 25 E89R I:Incoming Correspondence |
| REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED | 2010-09-16 | 26 89AG O:Outgoing Correspondence |
| REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) | 2010-09-16 | 27 RNL1 Q: |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2016-04-11 | 28 REAP I:Incoming Correspondence |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2016-04-11 | 29 ARAA I:Incoming Correspondence |
| COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED | 2020-08-14 | 30 REM2 E:E-Mail |
| TEAS CHANGE OF OWNER ADDRESS RECEIVED | 2020-09-22 | 31 COAR I:Incoming Correspondence |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2020-09-22 | 32 REAP I:Incoming Correspondence |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2020-09-22 | 33 ARAA I:Incoming Correspondence |
| TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | 2020-09-22 | 34 EWAF I:Incoming Correspondence |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2020-09-22 | 35 TCCA I:Incoming Correspondence |
| APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | 2020-09-22 | 36 CHAN I:Incoming Correspondence |
| TEAS SECTION 8 & 9 RECEIVED | 2021-06-24 | 37 E89R I:Incoming Correspondence |
| CASE ASSIGNED TO POST REGISTRATION PARALEGAL | 2021-11-08 | 38 APRE A:Allowance for Publication |
| REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED | 2021-11-08 | 39 89AG O:Outgoing Correspondence |
| REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS) | 2021-11-08 | 40 RNL2 Q: |
| NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED | 2021-11-08 | 41 NA89 E:E-Mail |
| AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | 2024-05-01 | 42 ASGN I:Incoming Correspondence |
| ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | 2024-06-20 | 43 ASCK I:Incoming Correspondence |
| ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | 2024-06-20 | 44 ASCK I:Incoming Correspondence |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 BLU-U 90201065 not registered Live/Pending |
DUSA Pharmaceuticals Inc. 2020-09-22 |
 BLU-U 75379349 2478294 Live/Registered |
DUSA Pharmaceuticals Inc. 1997-10-27 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 